Ghayas C. Issa

Sanam Loghavi: Cytomolecular Drivers of Relapse After Frontline FLT3 Inhibitor Therapy in FLT3-Mutated AML

Sanam Loghavi: Data-Driven Insights Refine Myeloid Neoplasm Classification

Sanam Loghavi: Relapse Patterns in NPM1-Mutated AML After Venetoclax-Based Therapy

Indraneel Deshmukh: Important data in FLT-3 TKD Mutated AML

Naveen Pemmaraju: Prognostic Impact of NPM1 Co-Mutation in FLT3-Mutated AML

Naveen Pemmaraju: Outcomes of Octa‐Nonagenarians with Newly Diagnosed Acute Myeloid Leukemia

Jayastu Senapati: Contemporary Outcomes of Octa‐Nonagenarians with ND-AML

Sanam Loghavi: CD123 Expression in AML To Assess CD123 Correlation with Genotype

Talha Badar: PII Trial of CPX-351 and Venetoclax

Aram Bidikian: 2025 ELN Recommendations on CML Treatment Milestones